Asensus Surgical, Inc.
(NYSE Amex Equities : ASXC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 4.16%163.117.5%$581.01m
MARAMarathon Patent Group, Inc. 17.40%23.080.4%$479.72m
PPDPPD, Inc. 0.07%46.120.0%$348.82m
CRLCharles River Laboratories International, Inc. 2.47%328.934.5%$296.24m
TALTAL Education Group 5.38%48.740.7%$232.53m
EFXEquifax, Inc. 1.05%239.512.0%$209.64m
ITGartner, Inc. 0.77%231.362.5%$150.22m
GGenpact Ltd. 0.32%44.657.0%$145.81m
CHGGChegg, Inc. 1.62%77.3013.4%$135.48m
FLTFLEETCOR Technologies, Inc. 1.54%272.853.6%$132.16m
PRAHPRA Health Sciences, Inc. 0.25%172.342.4%$108.94m
CPRTCopart, Inc. 3.02%124.134.4%$108.25m
SYNHSyneos Health, Inc. 0.59%85.750.0%$103.31m
PAGSPagSeguro Digital Ltd. 6.36%40.990.0%$88.26m
CDAYCeridian HCM Holding, Inc. 3.80%88.340.0%$79.78m

Company Profile

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.